BACE1 and Alzheimer disease: Placebo-treated 3×Tg-AD mice of 6 and 12 months compared with placebo-treated Non-Tg littermates showed a significant increase of APP and, despite no changes in BACE1 expression, exhibited a massive increase in Aβ(1–42) levels.